Xinle Cui

1.4k total citations
19 papers, 1.2k citations indexed

About

Xinle Cui is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Xinle Cui has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Xinle Cui's work include Herpesvirus Infections and Treatments (6 papers), Immune Response and Inflammation (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). Xinle Cui is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Immune Response and Inflammation (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). Xinle Cui collaborates with scholars based in United States, China and Japan. Xinle Cui's co-authors include Stewart J. Levine, Farshid N. Rouhani, Clifford M. Snapper, Feras Hawari, Christian A. Combs, Marion Lawrence, Zu-Xi Yu, Maryann Kaler, Andrew L. Snow and Swadhinya Arjunaraja and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Xinle Cui

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinle Cui United States 14 523 406 345 325 228 19 1.2k
Ramón Gimeno Spain 19 877 1.7× 347 0.9× 548 1.6× 258 0.8× 161 0.7× 42 1.5k
Margarida Souto‐Carneiro Portugal 18 742 1.4× 415 1.0× 172 0.5× 436 1.3× 91 0.4× 42 1.4k
Joachim R. Grün Germany 22 1.3k 2.5× 467 1.2× 282 0.8× 312 1.0× 145 0.6× 45 1.9k
Mercedesz Balázs United States 16 791 1.5× 302 0.7× 306 0.9× 111 0.3× 244 1.1× 32 1.4k
Joan Ní Gabhann Ireland 19 1.0k 1.9× 583 1.4× 258 0.7× 316 1.0× 188 0.8× 35 1.6k
Daniela Novick Israel 11 655 1.3× 364 0.9× 455 1.3× 103 0.3× 126 0.6× 13 1.1k
Stephen B. Gauld United States 21 1.2k 2.4× 361 0.9× 296 0.9× 120 0.4× 176 0.8× 40 1.8k
E Grau Garcia France 2 969 1.9× 195 0.5× 344 1.0× 201 0.6× 116 0.5× 2 1.4k
Guo‐Min Deng China 19 923 1.8× 304 0.7× 158 0.5× 490 1.5× 92 0.4× 41 1.4k
Satoshi Tanaka Japan 6 728 1.4× 229 0.6× 133 0.4× 192 0.6× 80 0.4× 7 1.1k

Countries citing papers authored by Xinle Cui

Since Specialization
Citations

This map shows the geographic impact of Xinle Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinle Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinle Cui more than expected).

Fields of papers citing papers by Xinle Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinle Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinle Cui. The network helps show where Xinle Cui may publish in the future.

Co-authorship network of co-authors of Xinle Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xinle Cui. A scholar is included among the top collaborators of Xinle Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinle Cui. Xinle Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhu, Huabin, Jie Qin, Luyao Wang, et al.. (2025). Lipid Nanoparticles Formulated with a Novel Cholesterol-Tailed Ionizable Lipid Markedly Increase mRNA Delivery Both in vitro and in vivo. International Journal of Nanomedicine. Volume 20. 9389–9405.
2.
Cui, Xinle & Clifford M. Snapper. (2021). Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Frontiers in Immunology. 12. 734471–734471. 109 indexed citations
5.
Cui, Xinle, Shuishu Wang, Michael Flora, et al.. (2019). Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity. International Journal of Molecular Sciences. 20(13). 3158–3158. 6 indexed citations
6.
Cui, Xinle & Clifford M. Snapper. (2019). Development of novel vaccines against human cytomegalovirus. Human Vaccines & Immunotherapeutics. 15(11). 2673–2683. 17 indexed citations
7.
Cui, Xinle, Shuishu Wang, Xiao Wang, et al.. (2018). Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response. Vaccine. 36(37). 5580–5590. 34 indexed citations
9.
Cui, Xinle, Goutam Sen, Gouri Chattopadhyay, et al.. (2013). A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine. Vaccine. 31(30). 3039–3045. 48 indexed citations
10.
Kocabaş, Can Naci, Sunita Kanswal, Margaret Kennedy, et al.. (2007). Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14. Cellular Microbiology. 9(5). 1297–1310. 19 indexed citations
11.
Levine, Stewart J., Barbara Adamik, Feras Hawari, et al.. (2005). Proteasome inhibition induces TNFR1 shedding from human airway epithelial (NCI-H292) cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 289(2). L233–L243. 20 indexed citations
12.
Cui, Xinle, et al.. (2004). Shedding of the Type II IL-1 Decoy Receptor Requires a Multifunctional Aminopeptidase, Aminopeptidase Regulator of TNF Receptor Type 1 Shedding.. The Journal of Immunology. 173(3). 2199–2199. 4 indexed citations
13.
Cui, Xinle, Farshid N. Rouhani, Feras Hawari, & Stewart J. Levine. (2004). An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding.. Journal of Biological Chemistry. 279(29). 30913–30913. 4 indexed citations
14.
Hawari, Feras, Farshid N. Rouhani, Xinle Cui, et al.. (2004). Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: A mechanism for generation of soluble cytokine receptors. Proceedings of the National Academy of Sciences. 101(5). 1297–1302. 177 indexed citations
15.
Cui, Xinle, et al.. (2003). Shedding of the Type II IL-1 Decoy Receptor Requires a Multifunctional Aminopeptidase, Aminopeptidase Regulator of TNF Receptor Type 1 Shedding. The Journal of Immunology. 171(12). 6814–6819. 154 indexed citations
16.
Cui, Xinle, et al.. (2003). An Aminopeptidase, ARTS-1, Is Required for Interleukin-6 Receptor Shedding. Journal of Biological Chemistry. 278(31). 28677–28685. 118 indexed citations
17.
Cui, Xinle, Feras Hawari, Marion Lawrence, et al.. (2002). Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. Journal of Clinical Investigation. 110(4). 515–526. 152 indexed citations
18.
Cui, Xinle, Feras Hawari, Marion Lawrence, et al.. (2002). Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. Journal of Clinical Investigation. 110(4). 515–526. 179 indexed citations
19.
Cui, Xinle, et al.. (2002). Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. Journal of Clinical Investigation. 110(4). 515–526. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026